Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesions

Introduction: Blue light cystoscopy (BLC) using hexaminolevulinate (Cysview(®)) improves the detection of nonmuscle invasive bladder cancer (NMIBC).(1–3) BLC results in lower recurrence rate and a better recurrence-free survival, as well as a progression benefit.(4) However, false-positive (FP) fluo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazargani, Soroush T., Djaladat, Hooman, Schuckman, Anne K., Hugen, Cory M., Daneshmand, Siamak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964243/
https://www.ncbi.nlm.nih.gov/pubmed/31976152
http://dx.doi.org/10.1089/vid.2017.0073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964243/
https://www.ncbi.nlm.nih.gov/pubmed/31976152
http://dx.doi.org/10.1089/vid.2017.0073

Ejemplares similares